Updates

October 15, 2019October 15, 2019
Mutations in Alpha-Synuclein Speed Protein Clumping in Familial Parkinson’s and Affect Severity, Study Finds

A detailed analysis of alpha-synuclein — a key protein involved in Parkinson’s — revealed how variants of this protein change over time, allowing researchers ... Read more
October 15, 2019October 15, 2019
Safety and Efficacy of Oral Cannabidiol in Treating Parkinson’s Psychosis Focus of Phase 2 Study in UK

A planned Phase 2 clinical trial will assess the safety and effectiveness of pharmaceutical-grade cannabidiol (CBD) in treating Parkinson’s-related psychosis. The trial was ... Read more
October 14, 2019October 10, 2019
We Share a Fear of Being a Burden, but We All Need Someone

“You’re not a burden. You’re a human.” –Anonymous It’s easy to feel alone when living with a chronic illness. You may think no one ... Read more
October 14, 2019October 14, 2019
Researchers Using Real-time Brain Mapping to Search for Therapeutic Targets in PD

Using its brain mapping platform, Inscopix will team up with researchers at the Broad Institute of MIT and Harvard to investigate how changes in ... Read more
October 14, 2019October 14, 2019
$20M Grant Awarded for Research into Imaging Protein Misfolding in Parkinson’s

The National Institute of Neurological Disorders and Stroke (NINDS) has awarded a five-year, $20 million grant to researchers looking for a way to image ... Read more

Columns, Dr. C's Journey with PD - a column by Dr. C

Letting Go Is Not ‘Forever Gone’
October 11, 2019October 9, 2019
“Letting go” is a constant theme with Parkinson’s disease. What used to be easy ...
News

Genetic Parkinson’s More Common Than Thought, Global Survey Reveals
October 11, 2019October 11, 2019
Cases of inherited Parkinson’s disease may be more frequent than previously reported, results from ...
News

FIRE-UP PD Initiative Seeks to Increase Inclusivity in Parkinson’s Research
October 11, 2019October 11, 2019
The Michael J. Fox Foundation (MJFF) and Massachusetts General Hospital have announced an initiative to ...
News

Potential Treatment to Prevent Toxic Protein Clumping Enters Phase 1 Trial, Yumanity Announces
October 10, 2019October 10, 2019
Yumanity Therapeutics announced the start of a Phase 1 clinical study in healthy volunteers that ...
News

MIT Scientists Building Artificial Gut to Study Bacteria’s Influence on Parkinson’s, Other Diseases
October 10, 2019October 10, 2019
MIT Lincoln Laboratory researchers are developing an artificial gut to study how the human ...
Columns, Journeying Through Parkinson's Disease   - a column by Sherri Woodbridge

True Grit Is What It Takes
October 9, 2019October 7, 2019
It seems to me that the word grit is on the lips of many ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

High Intensity Interval Training May Benefit Patients with Parkinson’s, Pilot Study Shows
October 9, 2019October 9, 2019
High intensity interval training for 12 weeks can significantly improve neuronal activity and delay ...
Middle-aged People Have Up to 20-Year Window to Reduce PD Risk, Oxford Health Policy Report Says
October 9, 2019October 9, 2019
In calling for a public health campaign to promote a brain-healthy lifestyle, an Oxford ...
Review Highlights Sex-related Differences In Parkinson’s
October 8, 2019October 8, 2019
Impaired Immune Cells May Contribute to Parkinson’s Progression, Study Suggests
October 8, 2019October 8, 2019
With Parkinson’s, the Good Is Worth the Fight
October 7, 2019October 3, 2019
Nuplazid ‘Significantly’ Slows Relapses in Dementia-Related Psychosis, Phase 3 Trial Shows
October 7, 2019October 7, 2019

Patients’ Self-reported Symptoms Reflect Clinical Assessments of Parkinson’s Severity, Study Finds
October 7, 2019October 7, 2019
A patient’s perception of how Parkinson’s disease affects their motor and non-motor skills reflects ...
A Scientific Model of Sanctuary Helps Me to Overcome Resistance
October 4, 2019October 2, 2019
Wearable Sensors Offer Way of Ably Monitoring Day-to-Day Movement in Parkinson’s Patients, Study Says
October 4, 2019October 4, 2019
Interaction of Gene Variants Dictates Parkinson’s Risk, Study Finds
October 4, 2019October 4, 2019

Empower Yourself by Making Good Choices
October 3, 2019September 30, 2019
Medication is more than the regimen of pills we take every day. Exercise, diet, ...
Phase 2 Trial of SEP-363856, Potential Oral Treatment of Parkinson’s Psychosis, Enrolling in US
October 3, 2019October 3, 2019
Silverstein Foundation, Q-State Launch Company Aiming to Treat Parkinson’s Linked to GBA Mutations
October 3, 2019October 3, 2019

Columns, Shaking Things Up - a Column by Mary Beth Skylis

James Parkinson’s Work Paved the Way for Future Research
October 2, 2019October 2, 2019
James Parkinson changed the course of medical history when he first described the “Shaking ...
Columns, Journeying Through Parkinson's Disease   - a column by Sherri Woodbridge

Are You a Victim or a Winner?
October 2, 2019September 30, 2019
When I think of a victim, I think of someone who has had something ...
News

Scientists Identify Potential Biomarker That Could Open New Avenues for Parkinson’s Treatment
October 2, 2019October 2, 2019
Researchers have found a compound that can rescue dopaminergic neurons from cell death and ...
News

LRRK2 Gene Mutation Protects Against Infection But Increases Parkinson’s Risk Via Inflammation, Study Suggests
October 2, 2019October 2, 2019
Although it may be protective against infections, a specific mutation in the LRRK2 gene ...
Columns, Slow is the New Fast - a Column by Jean Mellano

Parkinson’s Is My New Mountain
October 1, 2019September 27, 2019
In the spring of 2006, I was with a cycling group that headed out ...
News

Neuroscientist Awarded $2.9M NIH Grant to Study and Possibly Prevent Side Effects of Levodopa
October 1, 2019October 1, 2019
The National Institutes of Health has awarded a $2.9 million grant to a Feinstein Institutes ...
News

Nuplazid Eases Depression in Parkinson’s Patients, Phase 2 Trial Shows
October 1, 2019October 1, 2019
Treatment with Nuplazid (pimavanserin), approved in the U.S. for treating hallucinations and delusions associated ...
Columns, Journeying Through Parkinson's Disease   - a column by Sherri Woodbridge

Playing Helps to Calm a Blustery Day with Parkinson’s
September 30, 2019September 26, 2019
Fall is rapidly passing by, and with it goes your last opportunity to fly ...
News

Daily Use of Cala Trio Device Effectively Eases Hand Tremors, Trial Reports
September 30, 2019September 30, 2019
Using Cala Health’s non-invasive therapeutic device Cala Trio for 40 minutes twice daily effectively ...
News

Tavapadon Lessens Motor Symptoms in Patients with Early-stage Parkinson’s, Phase 2 Trial Finds
September 30, 2019September 30, 2019
Oral treatment with tavapadon eased motor symptoms and was well-tolerated by patients with early-stage ...
Columns, Dr. C's Journey with PD - a column by Dr. C

Stress Can Result in Resisting Sanctuary
September 27, 2019September 24, 2019
BOOM! Abruptly out of bed, I’m disoriented by flashing lights reflecting on the bedroom ...
News

Parkinson’s Foundation to Present Spanish-language Conference Oct. 19
September 27, 2019September 27, 2019
The Parkinson’s Foundation’s fourth annual Spanish-language conference, set for Oct. 19 in Norwalk, California, ...
News

Accordion Pill Enables Higher Optimal Doses of Levodopa Than Sinemet, Data Show
September 27, 2019September 27, 2019
Patients with Parkinson’s disease who were treated with Accordion Pill Carbidopa/Levodopa (AP-CD/LD) tolerated a higher dose ...
News

Mitsubishi Tanabe Pharma Shares Results from Phase 2 Study of ND0612 for Advanced Parkinson’s
September 26, 2019September 26, 2019
Continuous delivery of carbidopa/levodopa (CD/LD) with ND0612 under the skin led to quick improvement of ...
News

MJFF Announces $10M Challenge to Develop Critical Research Tool for Parkinson’s
September 26, 2019September 26, 2019
With the aim of opening entirely new avenues in Parkinson’s disease research and care, The ...

June 22, 2018June 22, 2018

New Tool Effectively Monitors Sleep Quality in Parkinson’s Patients, Researchers Say

News

A new tool called cardiopulmonary coupling could be used to effectively evaluate sleep quality in Parkinson’s disease patients, who often experience sleep disorders, according to a study. The study, “Assessment of sleep quality using cardiopulmonary coupling analysis in patients with ... Read more

Subscribe to our mailing list

Pin It on Pinterest